18 Pharma Companies Working on Fragile X Syndrome

As we near the end of 2015, we are busier than ever in our collaborations with pharmaceutical and biotech companies, large and small. FRAXA does much beyond funding research grants and fellowships. More and more these days, our work focuses on translating all that research we’ve funded since 1994 into treatments that will help our kids.

Last week, a long-time supporter asked: “how many companies is FRAXA working with right now, on Fragile X treatments?” We counted 18!  Certainly there are more as well.

Here are a few snapshots from this rapidly evolving scene:

These news tidbits are from just a few of the pharmaceutical companies pursuing Fragile X treatment development programs with FRAXA Research Foundation.